Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Global Business Travel Group, Inc.Global Business Travel Group Reports Q2 2025 Financial Results with Revenue Increase and Acquisition Progress
Shoals Technologies Group, Inc.Shoals Technologies Group Reports $110.8 Million Revenue in Q2 2025, Up 11.7%
Dorman Products, Inc.Dorman Products Reports 7.6% Revenue Growth in Q2 2025, Net Income Increases to $58.71 Million
Hillman Solutions Corp.Hillman Solutions Corp. Reports 6.2% Net Sales Increase and Rising Net Income for Recent Quarter
ImmunityBio, Inc.ImmunityBio Reports Significant Revenue Growth and Operational Developments for Q2 2025
Iterum Therapeutics plcIterum Therapeutics Reports Q2 2025 Financial Results with Increased Net Loss
Neuronetics, Inc.Neuronetics Reports 132% Revenue Growth to $38.1 Million in Latest Quarter
Foghorn Therapeutics Inc.Foghorn Therapeutics Reports Q2 2025 Financial Results with Increased Collaboration Revenue
Core Natural Resources, Inc.Core Natural Resources Reports $1.1 Billion Revenue in Q2 2025, Faces $36.6 Million Net Loss
PFIZER INCPfizer Reports $14.7 Billion Revenue in Q2 2025, 10% Increase Year-Over-Year
Boundless Bio, Inc.Boundless Bio Reports Q2 2025 Financial Results with $15.7 Million Net Loss
Beam Therapeutics Inc.Beam Therapeutics Reports $102.3 Million Net Loss in Q2 2025
ACRO BIOMEDICAL CO., LTD.ACRO Biomedical Reports No Revenue for Q2 2025, Increases Losses and Operating Expenses
Tango Therapeutics, Inc.Tango Therapeutics Reports 84% Revenue Decline and $38.9 Million Net Loss in Q2 2025
Orthofix Medical Inc.Orthofix Medical Reports 2.3% Sales Increase and Improved Net Loss in Q2 2025
First Watch Restaurant Group, Inc.First Watch Reports 19.1% Revenue Growth but Declines in Net Income in Q2 2025
MoonLake ImmunotherapeuticsMoonLake Immunotherapeutics Reports $56.1 Million Net Loss in Q2 2025
Sachem Capital Corp.Sachem Capital Reports Revenue Decline but Returns to Profitability in Q2 2025
W&T OFFSHORE INCW&T Offshore Reports $20.9 Million Net Loss in Q2 2025, Revenue Declines 14.3%
Pediatrix Medical Group, Inc.Pediatrix Medical Group Reports $468.8 Million Revenue and $39.3 Million Net Income in Q2 2025
Life Time Group Holdings, Inc.Life Time Group Holdings Reports 14% Revenue Growth to $761.5 Million in Q2 2025
JACOBS SOLUTIONS INC.Jacobs Solutions Inc. Reports 5.1% Revenue Growth to $3.03 Billion in Q3 Fiscal 2025
Vivid Seats Inc.Vivid Seats Reports 28% Revenue Decline and $263.3 Million Net Loss in Latest Quarter
Vigil Neuroscience, Inc.Vigil Neuroscience Reports $26.7 Million Net Loss in Q2 2025, Plans Merger with Sanofi
UR-ENERGY INCUr-Energy Reports $10.4 Million Revenue in Q2 2025, Despite Increased Net Loss